↓ Skip to main content

Reconvalescent plasma/camostat mesylate in early SARS-CoV-2 Q-PCR positive high-risk individuals (RES-Q-HR): a structured summary of a study protocol for a randomized controlled trial

Overview of attention for article published in Trials, May 2021
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (64th percentile)

Mentioned by

twitter
7 X users

Citations

dimensions_citation
7 Dimensions

Readers on

mendeley
310 Mendeley